Egfr T790m | List of Frontiers open access articles

Case Report

Published on 09 Jan 2023

Successful treatment of a patient with advanced lung adenocarcinoma (EGFR-T790M and C797S cis) with lazertinib: A case report and literature review

in Thoracic Oncology

Yue Fang
Qiankun Zhang
Weimin Wang
Juanjuan Tong
Xialin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1037964

3,265 views
1 citation

Case Report

Published on 14 Sep 2023

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

in Thoracic Oncology

Zhiqin Zhang
Jiamao Lin
Linke Yang
Yang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1188772

3,272 views
2 citations

Case Report

Published on 22 May 2018

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification

in Thoracic Oncology

Arenda D. Meedendorp
Arja ter Elst
Nils A. ’t Hart
Harry J. M. Groen
Ed Schuuring
Anthonie J. van der Wekken

Frontiers in Oncology

doi 10.3389/fonc.2018.00176

4,849 views
5 citations

Original Research

Published on 29 Sep 2021

Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment

in Cancer Imaging and Image-directed Interventions

Xin Tang
Yuan Li
Wei-feng Yan
Wen-lei Qian
Tong Pang
You-ling Gong
Zhi-gang Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.719919

7,311 views
33 citations

Original Research

Published on 30 Aug 2024

Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics

in Artificial Intelligence in Neurology

Xin Tang
Yuan Li
Wen-Lei Qian
Pei-Lun Han
Wei-Feng Yan
Zhi-Gang Yang

Frontiers in Neurology

doi 10.3389/fneur.2024.1399983

2,813 views
3 citations

Original Research

Published on 22 Mar 2021

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

in Thoracic Oncology

Liang Shi
Junfang Tang
Hong Tao
Lili Guo
Weihua Wu
Hongbo Wu
Zichen Liu
Li Tong
Wei Wu
Hongxia Li

Frontiers in Oncology

doi 10.3389/fonc.2021.622142

4,332 views
12 citations

Original Research

Published on 01 Oct 2021

A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance

in Cancer Molecular Targets and Therapeutics

Li Liu
Jingjing Qu
Jianfu Heng
Chunhua Zhou
Yi Xiong
Haiyan Yang
Wenjuan Jiang
Liang Zeng
Songlin Zhu
Yongchang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.722039

9,041 views
29 citations

Articles

Successful treatment of a patient with advanced lung adenocarcinoma (EGFR-T790M and C797S cis) with lazertinib: A case report and literature review

Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification

Machine Learning-Based CT Radiomics Analysis for Prognostic Prediction in Metastatic Non-Small Cell Lung Cancer Patients With EGFR-T790M Mutation Receiving Third-Generation EGFR-TKI Osimertinib Treatment

Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics

Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases

A Large Real-World Study on the Effectiveness of the Combined Inhibition of EGFR and MET in EGFR-Mutant Non-Small-Cell Lung Cancer After Development of EGFR-TKI Resistance